{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:32:39Z","timestamp":1765607559837,"version":"3.48.0"},"reference-count":26,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015371","name":"ReCor Medical","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100015371","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,9,8]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>A major issue confronting clinicians treating hypertension in pregnancy is the limited number of pharmacological options. Endovascular catheter-based renal denervation (RDN) is a new method to lower blood pressure (BP) in patients with hypertension by reducing the activity of the renal sympathetic nervous system. Drugs that affect this system are safe in pregnant women. So there is reasonable evidence that RDN performed before pregnancy should not have deleterious effects for the fetus. Because the efficacy of RDN may be greater in younger patients and in women, we may expect a larger proportion of BP normalisation in young hypertensive women, but this remains to be proven. Our primary objective is to quantify the proportion of BP normalisation with RDN in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>WHY-RDN is a multicentre randomised sham-controlled trial conducted in six French hypertension centres that will include 80\u2009women with essential hypertension treated or untreated, who are planning a pregnancy in the next 2\u2009years and will be randomly assigned to RDN or classic renal arteriography and sham RDN in a ratio of 1:1. The primary outcome is the normalisation of 24-hour BP (&lt;130\/80\u2009mm Hg) at 2-month post procedure off treatment. Sample size is calculated with the following assumptions: 5% one-sided significance level (\u03b1), 80% power (1-\u03b2), expected responder rates of 24% and 3% in the treatment and control group, respectively. Secondary outcomes include the absence of adverse outcomes for a future pregnancy, the variations of BP in ambulatory and home BP measurements and the evaluation of treatment prescribed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>WHY-RDN has been approved by the French Ethics Committee (Tours, Region Centre, Ouest 1- number 2021T1-28 HPS). This project is being carried out in accordance with national and international guidelines. The findings of this study will be disseminated by publication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05563337\">NCT05563337<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-071164","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T13:40:54Z","timestamp":1695994854000},"page":"e071164","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Endovascular ultrasound renal denervation to lower blood pressure in young hypertensive women planning pregnancy: study protocol for a multicentre randomised, blinded and sham controlled proof of concept study"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05563337","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5840-7749","authenticated-orcid":false,"given":"Philippe","family":"Gosse","sequence":"first","affiliation":[{"name":"Department of Cardiology\/Hypertension, University Hospital Centre Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efc","family":"Sentilhes","sequence":"additional","affiliation":[{"name":"University Hospital Centre Bordeaux, Bordeaux, France"},{"name":"University of Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Boulestreau","sequence":"additional","affiliation":[{"name":"Cardiologie\/Hypertension arterielle, University Hospital Centre Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Doublet","sequence":"additional","affiliation":[{"name":"Cardiologie\/Hypertension arterielle, University Hospital Centre Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Gaudissard","sequence":"additional","affiliation":[{"name":"Cardiologie\/Hypertension arterielle, University Hospital Centre Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Azizi","sequence":"additional","affiliation":[{"name":"Department of Hypertension, Hopital Europeen Georges Pompidou, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Cremer","sequence":"additional","affiliation":[{"name":"Cardiologie\/Hypertension arterielle, University Hospital Centre Bordeaux, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"2025121222274599000_13.9.e071164.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60279-6"},{"key":"2025121222274599000_13.9.e071164.2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.119.12968","article-title":"Changes in the prevalence of chronic hypertension in pregnancy, United States","volume":"74","author":"Ananth","year":"2019","journal-title":"Hypertension"},{"key":"2025121222274599000_13.9.e071164.3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14767058.2017.1390742","article-title":"Chronic hypertension: effect of blood pressure control on pregnancy outcome","volume":"32","author":"Panaitescu","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025121222274599000_13.9.e071164.4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.117.10689","article-title":"Influence of gestational age at initiation of antihypertensive therapy: secondary analysis of CHIPS trial data (control of hypertension in pregnancy study)","volume":"71","author":"Pels","year":"2018","journal-title":"Hypertension"},{"key":"2025121222274599000_13.9.e071164.5","article-title":"Treatment for mild chronic hypertension during pregnancy. reply","volume":"387","author":"Tita","year":"2022","journal-title":"N Engl J Med"},{"key":"2025121222274599000_13.9.e071164.6","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N Engl J Med"},{"key":"2025121222274599000_13.9.e071164.7","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13802"},{"key":"2025121222274599000_13.9.e071164.8","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00816","article-title":"Autonomic dysfunction in Preeclampsia: A systematic review","volume":"10","author":"Yousif","year":"2019","journal-title":"Front Neurol"},{"key":"2025121222274599000_13.9.e071164.9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/HYPERTENSIONAHA.117.10766","article-title":"Sympathetic nervous system regulation in human normotensive and hypertensive pregnancies","volume":"71","author":"Reyes","year":"2018","journal-title":"Hypertension"},{"key":"2025121222274599000_13.9.e071164.10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/HYPERTENSIONAHA.119.14107","article-title":"Clinical influence of Nonadherence with prophylactic aspirin in preventing Preeclampsia in high-risk pregnancies: A multicenter, prospective, observational cohort study","volume":"75","author":"Shanmugalingam","year":"2020","journal-title":"Hypertension"},{"key":"2025121222274599000_13.9.e071164.11","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.119.13616"},{"key":"2025121222274599000_13.9.e071164.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60566-3"},{"key":"2025121222274599000_13.9.e071164.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61942-5"},{"key":"2025121222274599000_13.9.e071164.14","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal Denervation to treat hypertension (RADIANCE-HTN SOLO): a Multicentre, International, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"key":"2025121222274599000_13.9.e071164.15","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1161\/CIRCULATIONAHA.119.040451","article-title":"Six-month results of treatment-blinded medication titration for hypertension control following randomization to Endovascular ultrasound renal Denervation or a sham procedure in the RADIANCE-HTN SOLO trial","volume":"139","author":"Azizi","year":"2019","journal-title":"Circulation"},{"key":"2025121222274599000_13.9.e071164.16","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1097\/HJH.0000000000002190","article-title":"Blood pressure changes after renal Denervation are more pronounced in women and nondiabetic patients: findings from the Austrian Transcatheter renal Denervation Registry","volume":"37","author":"Zweiker","year":"2019","journal-title":"J Hypertens"},{"key":"2025121222274599000_13.9.e071164.17","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/HJH.0000000000001739","article-title":"Predictors for profound blood pressure response in patients undergoing renal sympathetic Denervation","volume":"36","author":"Fengler","year":"2018","journal-title":"J Hypertens"},{"key":"2025121222274599000_13.9.e071164.18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9378(86)90681-2","article-title":"Circulatory responses to Hypovolemia in the pregnant and Nonpregnant sheep after pharmacologic sympathectomy","volume":"154","author":"Tabsh","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"2025121222274599000_13.9.e071164.19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.preghy.2018.02.011","article-title":"To study the changes in fetal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension","volume":"15","author":"Gainder","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"2025121222274599000_13.9.e071164.20","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2016-103955"},{"key":"2025121222274599000_13.9.e071164.21","article-title":"Renal Denervation for resistant hypertension","volume":"371","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"2025121222274599000_13.9.e071164.22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal Denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED pivotal): a Multicentre, randomised, sham-controlled trial","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"key":"2025121222274599000_13.9.e071164.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30951-6"},{"key":"2025121222274599000_13.9.e071164.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz118"},{"key":"2025121222274599000_13.9.e071164.25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/HJH.0000000000001517","article-title":"Renal sympathetic Denervation in Sweden: a report from the Swedish Registry for renal Denervation","volume":"36","author":"V\u00f6lz","year":"2018","journal-title":"J Hypertens"},{"key":"2025121222274599000_13.9.e071164.26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht197"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-071164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:27:53Z","timestamp":1765607273000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-071164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,29]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/bmjopen-2022-071164"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-071164","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}